Kéri Pharma Hungary

Kéri Pharma is a Hungarian pharmaceutical company dedicated to the development and manufacturing of over-the-counter medicines. They have pioneered a 1000 mg micronized pure diosmine formulation specifically designed to address chronic venous insufficiency and haemorrhoids. Their flagship product, Dimotec, is a once-daily treatment with a diosmine content that surpasses that of competing combination products. Kéri Pharma operates on a global scale, offering their products for licensing based on their Western Europe dossier and Zone IV/B stability data.

Services include:
- Contract Development and Manufacturing (CDMO)
- Research and Development
- Quality Control and Assurance
- Regulatory Affairs Support
- Product Testing and Stability Studies
- Distribution Services

Kéri Pharma Hungary stands out as a reliable partner in the pharmaceutical industry, bringing innovative solutions to market with their focus on quality and efficiency. For further information, visit keripharma.hu.